<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>Oxford, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">gkf244</article-id><article-id pub-id-type="pmid">11917009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Physical and functional interactions of the tumor suppressor protein p53 and DNA polymerase &#x003b1;-primase</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Melle</surname><given-names>Christian</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nasheuer</surname><given-names>Heinz-Peter</given-names></name><xref ref-type="author-notes" rid="N0x8affd10.0x99fbb00">a</xref></contrib></contrib-group><aff id="N0x8affd10.0x99fbb20">Institut f&#x000fc;r Molekulare Biotechnologie e.V., Abteilung Biochemie, Beutenbergstrasse 11, D-07745 Jena, Germany</aff><author-notes><fn id="N0x8affd10.0x99fbb00"><label>a</label><p>To whom correspondence should be addressed. Tel: &#x0002b;49 3641 656290; Fax: &#x0002b;49 3641 656288; Email: nasheuer&#x00040;imb-jena.de Present address:Christian Melle, Institut f&#x000fc;r Humangenetik und Anthropologie, Friedrich-Schiller-Universit&#x000e4;t, Kollegiengasse 10, D-07740 Jena, Germany</p></fn></author-notes><pub-date pub-type="ppub"><day>1</day><month>4</month><year>2002</year></pub-date><volume>30</volume><issue>7</issue><fpage>1493</fpage><lpage>1499</lpage><ext-link ext-link-type="uri" xlink:href="http:&#x0002f;&#x0002f;www.nar.oupjournals.org&#x0002f;content&#x0002f;vol30&#x0002f;issue7&#x0002f;"/><history><date date-type="received"><day>15</day><month>1</month><year>2002</year></date><date date-type="accepted"><day>4</day><month>2</month><year>2002</year></date></history><copyright-statement>Copyright &#x000a9; 2002 Oxford University Press</copyright-statement><copyright-year>2002</copyright-year><abstract><p>The wild-type form of p53 contains an intrinsic 3&#x02032;&#x02013;5&#x02032;-exonuclease activity. As p53 forms a complex with DNA polymerase &#x003b1;-primase (pol-prim) <italic>in vivo</italic> this finding suggests that p53 might cooperate with pol-prim to stabilize the genetic information of living cells. To test this hypothesis, exonuclease-free DNA pol-prim was expressed alone or together with p53 for purification. Pol-prim formed a complex with p53, which was purified by ion exchange and immunoaffinity chromatography from baculovirus-infected insect cells. The p53-containing pol-prim fractions removed a 3&#x02032;-unpaired nucleotide with a 1.5&#x02013;2-fold higher rate than a paired nucleotide, whereas the four subunit pol-prim did not have any exonuclase activity. Therefore, only p53&#x0002f;pol-prim was able to elongate a primer-template that contained a 3&#x02032;-unpaired primer end <italic>in vitro</italic>. To achieve this, the 3&#x02032;&#x02013;5&#x02032;-exonuclease activity of p53 excised the unpaired nucleotide at the 3&#x02032;-end of the primer and created a paired 3&#x02032;-end, which pol-prim was able to elongate. The exonuclease activity of p53 as well as the elongation of a primer with a mispaired 3&#x02032;-end was inhibited specifically by the anti-p53 monoclonal antibodies PAb240 and PAb421.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>The tumor suppressor protein p53 has multiple functions in preventing cellular growth and tumor development by conserving genetic integrity in mammalian cells (<xref ref-type="bibr" rid="gkf244c1">1</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c7">7</xref>). The loss or functional inactivation of p53 greatly enhances the risk of malignant transformation of cells. These findings underline its critical role in preventing cancer and indeed &#x0223c;50&#x00025; of all human tumors contain mutant p53 genes (<xref ref-type="bibr" rid="gkf244c8">8</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c10">10</xref>). In contrast to its recently discovered homologs (<xref ref-type="bibr" rid="gkf244c11">11</xref>,<xref ref-type="bibr" rid="gkf244c12">12</xref>) and despite its central functions in cancer, p53 is not essential for the development and growth of cells (<xref ref-type="bibr" rid="gkf244c13">13</xref>).</p><p>Analysis of p53 functions and their regulation have led to a model for a complex network of activities (<xref ref-type="bibr" rid="gkf244c14">14</xref>). Wild-type p53 is involved in the regulation of the cell cycle as a transactivator of important regulatory proteins (<xref ref-type="bibr" rid="gkf244c15">15</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c18">18</xref>), in DNA repair by interacting with essential repair proteins (<xref ref-type="bibr" rid="gkf244c19">19</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c22">22</xref>) and is probably directly involved in cellular DNA replication (<xref ref-type="bibr" rid="gkf244c23">23</xref>), as well as in recombination events (<xref ref-type="bibr" rid="gkf244c24">24</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c27">27</xref>). Furthermore, it binds to DNA polymerase &#x003b1;-primase (pol-prim) and to the eukaryotic single-stranded DNA-binding protein, replication protein A (RPA) (<xref ref-type="bibr" rid="gkf244c28">28</xref>,<xref ref-type="bibr" rid="gkf244c29">29</xref>). In addition, it was shown that p53 contains an intrinsic 3&#x02032;&#x02013;5&#x02032;-exonuclease activity, which might play a role in DNA replication or repair (<xref ref-type="bibr" rid="gkf244c30">30</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c32">32</xref>). Recently, it was shown that the p53 exonuclease activity has a proofreading capacity to enhance the fidelity of reverse transcriptase (RT) of the murine leukemia virus (MLV) and of the human immunodeficiency virus (HIV; <xref ref-type="bibr" rid="gkf244c33">33</xref>,<xref ref-type="bibr" rid="gkf244c34">34</xref>). As two eukaryotic DNA polymerases, DNA pol-prim and DNA polymerase &#x003b2;, do not possess an intrinsic proofreading exonuclease (<xref ref-type="bibr" rid="gkf244c35">35</xref>), it was hypothesized that p53 fulfills this function (<xref ref-type="bibr" rid="gkf244c30">30</xref>,<xref ref-type="bibr" rid="gkf244c36">36</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c38">38</xref>). This possibility is underlined by the fact that several preparations of pol-prim were described that were associated with an exonuclease activity (<xref ref-type="bibr" rid="gkf244c39">39</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c41">41</xref>). Recently, a direct interaction of DNA polymerase &#x003b2; and p53 was shown that is responsible for increased base excision repair activity (<xref ref-type="bibr" rid="gkf244c42">42</xref>).</p><p>Eukaryotic DNA replication is a highly accurate process that results in error rates of &#x0223c;10<sup>&#x02013;10</sup> misincorporated nucleotides per base and cell doubling (<xref ref-type="bibr" rid="gkf244c43">43</xref>). Such a high accuracy is achieved by a mechanism consisting of a minimum of three steps, which are the nucleotide selection of the replicative DNA polymerase, proofreading and post-replicative mismatch repair (MMR). A decrease in the fidelity of DNA replication would lead to genomic instability and result in an increased risk of cancer (<xref ref-type="bibr" rid="gkf244c44">44</xref>,<xref ref-type="bibr" rid="gkf244c45">45</xref>). It was shown that even in the early stages of the cellular transformation process high incidences of mutations occur (<xref ref-type="bibr" rid="gkf244c46">46</xref>), which might well be caused by misinsertion and proofreading defects of replicative DNA polymerases. In analogy to defects of MMR genes, such defects are expected to contribute considerably to the formation and propagation of cancers. Taking these findings into account, the exonuclease activity of p53 might contribute a proofreading function to cellular DNA polymerases and thereby increase the fidelity of the cellular DNA synthesis process.</p><p>The present study was conducted to characterize the interaction of pol-prim and p53 and to investigate in this respect the intrinsic 3&#x02032;&#x02013;5&#x02032;-exonuclease activity of p53 <italic>in vitro</italic>. This study shows for the first time the existence <italic>in vivo</italic> of a complex of pol-prim and p53 as identified by immunoprecipitation and the interplay of the DNA polymerase with the 3&#x02032;&#x02013;5&#x02032;-exonuclease activity of the p53&#x0002f;pol-prim complex. Preparations of pol-prim containing p53 degraded preferentially unpaired versus paired 3&#x02032;-ends whereas pol-prim without p53 did not have any exonuclease activity. p53&#x0002f;pol-prim exchanged a 3&#x02032;-end mispair against the correct nucleotide, whereas pol-prim alone did not.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Protein purification</title><p>The four subunits of pol-prim were overproduced by infection of High Five insect cells (Invitrogen, Heidelberg) with the appropriate baculoviruses (<xref ref-type="bibr" rid="gkf244c47">47</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c50">50</xref>). Human p53 was also expressed by infection of insect cells with recombinant baculoviruses (<xref ref-type="bibr" rid="gkf244c51">51</xref>), and purified as described (<xref ref-type="bibr" rid="gkf244c31">31</xref>). A complex consisting of pol-prim and p53 was overproduced in High Five insect cells by infection with the corresponding five baculoviruses. Pol-prim, as well as the p53&#x0002f;pol-prim complex, was purified by phosphocellulose chromatography and immunoaffinity chromatography using immobilized monoclonal antibody SJK 237-71 directed to the p180 subunit of pol-prim and subsequent alkaline elution (<xref ref-type="bibr" rid="gkf244c52">52</xref>,<xref ref-type="bibr" rid="gkf244c53">53</xref>).</p></sec><sec><title>Immunoprecipitation</title><p>The antibodies HP180-12 and PAb101 were bound to protein G&#x02013;Sepharose beads and crosslinked on beads with dimethyl-pimelimidate (<xref ref-type="bibr" rid="gkf244c54">54</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c56">56</xref>). Crude extracts (850 &#x000b5;l) from human CEM cells were incubated with anti-pol-prim monoclonal HP180-12, which recognizes the large subunit p180 to immunoprecipitate protein complex for 1 h at 4&#x000b0;C (<xref ref-type="bibr" rid="gkf244c54">54</xref>). The anti-SV40 T-Ag monoclonal antibody PAb101 served as a negative control. Then the resins were washed three times with 20 mM HEPES&#x02013;KOH pH 8, 25 mM KCl, 5 mM MgCl<sub>2</sub>, 0.1 mM EDTA and 0.05&#x00025; NP-40. Bound proteins were subjected to 10&#x00025; SDS&#x02013;PAGE and detected by immunoblotting with anti-p180 monoclonal antibody HP180-7 (<xref ref-type="bibr" rid="gkf244c54">54</xref>) and anti-p53 polyclonal antibody Ab-7 (Calbiochem).</p></sec><sec><title>DNA polymerase assay</title><p>The activity of pol-prim was determined with activated calf thymus DNA as described elsewhere (<xref ref-type="bibr" rid="gkf244c57">57</xref>). Furthermore, DNA polymerase &#x003b1; activity was analyzed by denaturating gel electrophoresis. If not indicated otherwise the 16-base primer 1 (5&#x02032;-GTA ACT TTT CCC AGC C-3&#x02032;) corresponding to the position AB 5278&#x02013;5293 of the &#x003a6;X174am16 genome, which includes the amber16 codon, was radioactively labeled at its 5&#x02032;-end with T4-polynucleotide kinase (Biolabs) and &#x0005b;&#x003b3;-<sup>32</sup>P&#x0005d;ATP (Amersham Bioscience). Then it was hybridized to the 63mer template oligonucleotide (5&#x02032;-GTT CAA CCA GAT ATT GAA GCA GAA CGC AAA AAG AGA GAT GAG ATT TAG GCT GGG AAA AGT TAC-3&#x02032;) derived from the &#x003a6;X174am16 sequence according to standard procedures (<xref ref-type="bibr" rid="gkf244c58">58</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c60">60</xref>). The 16-base primer 2 (5&#x02032;-GTA ACT TTT CCC AGC G-3&#x02032;) led to a 3&#x02032;-terminal mispair when hybridized to the 63mer oligonucleotide and was treated as described for primer 1. These template-primer systems were used as substrates for pol-prim alone or p53-containing pol-prim complexes as indicated. Reaction mixtures contained 50&#x000a0;mM Tris&#x02013;acetate, pH 7.5, 10 mM potassium acetate, 6 mM magnesium acetate, 1 mM dithiothreitol, 0.1 mg&#x0002f;ml bovine serum albumin, 0.05 mM (each) of the four dNTPs, and the indicated concentrations of DNA substrates (<xref ref-type="bibr" rid="gkf244c57">57</xref>). The reaction was stopped by adding loading buffer (90&#x00025; formamide, 10&#x000a0;mM EDTA, 0.1&#x00025; bromphenol blue and 0.18&#x00025; xylene cyanol FF) and heating the mixture to 90&#x000b0;C. Products were analyzed on 20&#x00025; polyacrylamide gels containing 7 M urea followed by autoradiography using PhosphorImager screens (Amersham Bioscience) at &#x02013;20&#x000b0;C or Biomax films (Kodak) at &#x02013;80&#x000b0;C. PhosphorImager autoradiographies were quantified with the ImageQuant program (Amersham Bioscience).</p></sec><sec><title>Exonuclease assay</title><p>The exonuclease activity was analyzed with the same primer-template systems as described above. The reaction was performed in 50 mM Tris&#x02013;acetate, pH 8.5, 10 mM magnesium acetate, 1 mM dithiothreitol, 0.1 mg&#x0002f;ml bovine serum albumin and radioactively labeled primers (<xref ref-type="bibr" rid="gkf244c59">59</xref>). The reaction was started by adding 2&#x02013;5 ng of p53 or 5&#x02013;10 ng of p53-containing pol-prim at 37&#x000b0;C for 15 min or the time indicated. The reaction was stopped by adding loading buffer and heating to 90&#x000b0;C. Products were analyzed as described above.</p></sec><sec><title>Other techniques</title><p>Protein concentrations were determined by the method of Bradford using bovine serum albumin as a standard (<xref ref-type="bibr" rid="gkf244c61">61</xref>). Antibodies were either purified from hybridoma supernatants or rabbit serum by protein A&#x02013;agarose chromatography (Dianova, Hamburg) as described (<xref ref-type="bibr" rid="gkf244c56">56</xref>). The purity of the antibodies and the other proteins was determined to be &#x0003e;90&#x00025; by gel electrophoresis through a denaturing 10&#x00025; polyacrylamide gel.</p></sec></sec><sec><title>RESULTS</title><sec><title>Immunoprecipitation of p53&#x0002f;pol-prim from human cells</title><p>The monoclonal antibodies HP180-12 and SJK237-71, which recognize the p180 subunit of human pol-prim, immunoprecipitated pol-prim and p53 from human crude extracts (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>A, lane 5, and data not shown). In parallel, the monoclonal antibody PAb101 did not precipitate pol &#x003b1; or p53 from the crude extracts (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>A, lane 3). The data suggest that p53 interacts with pol-prim in human cells.</p></sec><sec><title>Purification of an enzyme complex consisting of pol-prim and p53 from baculovirus-infected insect cells</title><p>After co-infecting cells with recombinant baculoviruses encoding the four subunits of human pol-prim and p53, p53-containing pol-prim fractions were obtained by phosphocellulose and immunoaffinity chromatography using monoclonal antibodies directed against the largest subunit, p180, of pol-prim (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>B, lane 3). The immunoaffinity-purified p53&#x0002f;pol-prim complex was stable during gel filtration (data not shown). Omitting the p53-encoding baculovirus yielded a four subunit pol-prim complex (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>B, lane 1). The affinity-purified p53&#x0002f;pol-prim fraction displayed a purity of at least 95&#x00025;, with regard to the four pol-prim subunits and the accompanying p53 (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>B, lane 3). The eluate from the immunoaffinity resin was dialyzed against storage buffer and stored at &#x02013;80&#x000b0;C for further use. These enzyme complexes either had only DNA polymerase and primase activity (heterotetrameric pol-prim), or had DNA polymerase, primase, as well as 3&#x02032;&#x02013;5&#x02032;-exonuclease activity (Fig. <xref ref-type="fig" rid="gkf244f2">2</xref>A).</p><p>When expressed alone, recombinant p53 was purified by phosphocellulose chromatography and subsequent immunoaffinity chromatography using the immobilized monoclonal antibody PAb421 directed against the C-terminus of p53 (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>B, lane 2). Both p53-containing fractions also displayed 3&#x02032;&#x02013;5&#x02032;-exonuclease activity. The p53 subunit of the enzyme complex or p53 alone possessed similar running properties in the gel and the proteins were highly purified (Fig. <xref ref-type="fig" rid="gkf244f1">1</xref>B).</p></sec><sec><title>Only p53-containing pol-prim showed 3&#x02032;&#x02013;5&#x02032;-exonuclease activity</title><p>Affinity-purified pol-prim either alone or from cells co-infected with p53-encoding baculoviruses was subjected to exonuclease assays. Only p53-containing fractions of pol-prim displayed exonuclease activity whose biochemical characteristics were identical to those of the previously purified p53 alone (Fig. <xref ref-type="fig" rid="gkf244f2">2</xref>A, lanes 1 and 2) (<xref ref-type="bibr" rid="gkf244c31">31</xref>). These included a 3&#x02032;&#x02013;5&#x02032; directionality (data not shown), a distributive rather than a processive mode of excision and a pattern of products that was indistinguishable from that obtained with p53 alone. On the other hand, pol-prim without p53, which was purified in parallel, did not display exonuclease activity (Fig. <xref ref-type="fig" rid="gkf244f2">2</xref>A, lanes 3 and 4). The exonuclease of the isolated p53&#x0002f;pol-prim complex excised mismatched G-G nucleotides over matched nucleotides G-C with a ratio of about 1.8:1 after 0.5 and 2 min (Fig. <xref ref-type="fig" rid="gkf244f2">2</xref>B, lanes 1, 2, 5 and 6). Further characterization revealed that the antibodies PAb240 and PAb421, but not the antibody DO-1, inhibited the p53 exonuclease activity (Fig. <xref ref-type="fig" rid="gkf244f3">3</xref>, lanes 4&#x02013;6, 7&#x02013;9 and 1&#x02013;3, respectively).</p></sec><sec><title>p53-containing pol-prim but not the p53-free form of pol-prim allowed the elongation of a mispaired 3&#x02032;-end</title><p>To study the cooperation of the exonuclease and DNA polymerase functions of p53&#x0002f;pol-prim, we conducted two synthetic 16&#x0002f;63mer template-primer systems, one containing a G:G mispair at its 3&#x02032;-end and the other with a paired end. The latter was used efficiently as a substrate by both the pol-prim complex with and the one without p53, and both enzyme complexes had strong and comparable DNA synthesizing activities (Fig. <xref ref-type="fig" rid="gkf244f4">4</xref>A and B, lanes 1&#x02013;4). In contrast, the mispaired primer was exclusively elongated by the p53-containing enzyme complex (compare Fig. <xref ref-type="fig" rid="gkf244f4">4</xref>A and B, lanes 5&#x02013;8). In addition to DNA synthesis activity, p53&#x0002f;pol-prim shows products resulting from 3&#x02032;&#x02013;5&#x02032;-exonuclease activity when using the mispaired primer (Fig. <xref ref-type="fig" rid="gkf244f4">4</xref>A, lanes 7 and 8). The elongation of the mispaired primer was inhibited by the p53-specific antibodies PAb421 and PAb240 but not by heat-denaturated antibodies or by the p53-specific antibody DO-1 (Fig. <xref ref-type="fig" rid="gkf244f5">5</xref>, compare lanes 1&#x02013;3 with lanes 4&#x02013;6; data not shown). This inhibition of the elongation reaction was most probably caused by abolishing the p53 exonuclease activity (Fig. <xref ref-type="fig" rid="gkf244f3">3</xref>). These findings strongly suggest that the p53-associated exonuclease from the p53&#x0002f;pol-prim complex was mandatory for the subsequent elongation of the mispaired primer by DNA polymerase &#x003b1;.</p><p>To study the exchange of a mispaired base the incorporation of the correct nucleotide and another mispaired nucleotide was investigated. During incubation of the mispaired 3&#x02032;-end in the presence of the correct dNTP, p53-containing pol-prim removed the incorrect dGMP and replaced it with the correctly paired dCMP (Fig. <xref ref-type="fig" rid="gkf244f6">6</xref>B, lanes 6&#x02013;10). Such a replacement reaction was not detected with pol-prim alone and no products were detected (data not shown). In contrast, p53-containing pol-prim did not detectably incorporate an incorrect dNMP, such as dAMP, at the 3&#x02032;-end instead of the mispaired dGMP (Fig. <xref ref-type="fig" rid="gkf244f6">6</xref>C, lanes 11&#x02013;15). It is worth mentioning that the replacement of an incorrect nucleotide was rather slow (Fig. <xref ref-type="fig" rid="gkf244f6">6</xref>B, lanes 6&#x02013;10). Elongation of a correctly paired primer was 50&#x00025; complete within 30 s (Fig. <xref ref-type="fig" rid="gkf244f6">6</xref>A, lanes 1&#x02013;5) whereas significant amounts of product from the exchange reaction were only detectable after 5&#x02013;10 min (Fig. <xref ref-type="fig" rid="gkf244f6">6</xref>B, lanes 6&#x02013;10). The data suggest that the exonuclease was too slow, that additional factors such as RPA were missing in the assay system, or that&#x000a0;specific modifications might be required for an optimal cooperation of pol-prim and the p53 exonuclease activity. For this reason the effects of RPA on this nucleotide exchange assay were examined. A reproducible, 1.5&#x02013;2-fold increased rate of DNA synthesis by p53&#x0002f;pol-prim on mispaired primer-template was observed in the presence of RPA (data not shown). This indicates that additional factors or modifications may be necessary for a satisfactory rate of DNA synthesis in this type of assay.</p></sec></sec><sec><title>DISCUSSION</title><p>The finding that p53 possesses a 3&#x02032;&#x02013;5&#x02032;-exonuclease activity and that p53 forms a complex with the replicative pol-prim, which does not contain an intrinsic 3&#x02032;&#x02013;5&#x02032;-exonuclease activity (<xref ref-type="bibr" rid="gkf244c29">29</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c38">38</xref>), leads to the question of whether p53 can act as a proofreader for this particular DNA polymerase and whether it increases the fidelity of DNA replication. Using independently purified pol-prim and p53 from cultured cells, it was suggested that p53 might increase the accuracy of DNA polymerase &#x003b1; by excising potential DNA polymerase errors at the 3&#x02032;-end (<xref ref-type="bibr" rid="gkf244c30">30</xref>). The observation that p53 interacts directly with pol-prim (<xref ref-type="bibr" rid="gkf244c29">29</xref>) was further extended and it was determined that p53 binds physically to pol-prim <italic>in vivo</italic> and that these proteins could be immunoprecipitated. Moreover, both enzymes p53 and pol-prim co-purified as a complex which was stable enough to sustain gel filtration (data not shown). Hereby, only a complex containing recombinant p53 and pol-prim possessed 3&#x02032;&#x02013;5&#x02032;-exonuclease as well as DNA polymerase activity, and could remove the 3&#x02032;-mispaired base of a primer, and elongated such a substrate whereas neither of these proteins alone could elongate such a primer.</p><p>As pol-prim is an essential replicative enzyme complex which lacks a proofreader, it has been hypothesized that errors made by this DNA polymerase can be corrected by the exonucleases of either DNA polymerases &#x003b4; or &#x0025b; (<xref ref-type="bibr" rid="gkf244c62">62</xref>). Another suggestion is that the primer-removing apparatus consisting of DNA helicase&#x0002f;endonuclease DNA2 and endonuclease FEN-1 removes that part of a nascent Okazaki fragment which has been synthesized by DNA polymerase &#x003b1; (<xref ref-type="bibr" rid="gkf244c63">63</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c65">65</xref>). Although the failure to find an efficient proofreading function for the p53&#x0002f;pol-prim complex would be in accord with the earlier observation that transgenic mice with an impaired p53 function do not exhibit a measurable increase in the frequency of point mutations <italic>in vivo</italic> (<xref ref-type="bibr" rid="gkf244c66">66</xref>,<xref ref-type="bibr" rid="gkf244c67">67</xref>), a more recent study reported a 2.3-fold higher mutation frequency in thymic lymphomas of p53<sup>&#x02013;&#x0002f;&#x02013;</sup> mice relative to that of the p53<sup>&#x0002b;&#x0002f;&#x0002b;</sup> control (<xref ref-type="bibr" rid="gkf244c68">68</xref>). Furthermore, inactivation of p53 by the HPV16 E6 protein increased mutagenesis at the HPTR locus in human cells (<xref ref-type="bibr" rid="gkf244c69">69</xref>).</p><p>After purification of p53&#x0002f;pol-prim, the functional cooperation of DNA polymerase and exonuclease activity was studied using various <italic>in vitro</italic> assays. p53-containing pol-prim excised preferentially a 3&#x02032;-mispaired primer end over a paired one. Furthermore, during this reaction the enzyme complex removed a terminal mispaired nucleotide present on a primer-template complex and replaced it with a correctly paired nucleotide. When all four dNTP substrates were in the reaction mixture, p53-containing pol-prim but not pol-prim alone was able to elongate a mispaired primer end (data not shown). p53&#x000a0;in the absence of pol-prim subunits generated only exonuclease products in this reaction mixture. It is the first time that the elongation of a mispaired substrate has been shown in addition to the excision of the mispaired nucleotide.</p><p>This reaction is p53 specific because in the presence of the exonuclease-inhibiting antibodies Pab421 and PAb240 p53&#x0002f;pol-prim could not extend a 3&#x02032; mispair similarly as reported before (<xref ref-type="bibr" rid="gkf244c30">30</xref>,<xref ref-type="bibr" rid="gkf244c32">32</xref>). These findings give further credit to the view that the exonuclease associated with p53 is an intrinsic part of this protein. In contrast with wild-type p53, a pol-prim complex containing the hot spot mutant p53R248H did not display exonuclease activity and did not elongate a mispaired 3&#x02032;-end (<xref ref-type="bibr" rid="gkf244c70">70</xref>). These results confirm and extend the already published observations that the exonuclease activity of p53 degrades duplex DNA with a mismatch more rapidly than matched DNA and that p53 suppresses the incorporation of unpaired nucleotides by pol-prim (<xref ref-type="bibr" rid="gkf244c30">30</xref>,<xref ref-type="bibr" rid="gkf244c32">32</xref>&#x02013;<xref ref-type="bibr" rid="gkf244c34">34</xref>). These <italic>in vitro</italic> findings supported the view that p53 might fulfill a proofreading function for pol-prim.</p><p>The p53&#x0002f;pol-prim complex can exchange a 3&#x02032; end mispaired with a correctly paired end but the efficiency of subsequent elongation of this newly generated paired end is poor compared with the elongation of the correctly paired end substrate. One obvious speculative explanation for this observation is that the exonuclease and the DNA polymerase activity of this purified enzyme complex do not fully cooperate. This suggestion is underlined by the finding that p53&#x0002f;pol-prim elongates a paired 3&#x02032;-end as efficiently as does pol-prim although the exonuclease efficiently removes a mispaired nucleotide. The elongation activity of the complex appears hindered in elongating the newly formed paired primer end. These exchange and subsequent elongation processes are probably too slow in this purified system to be of benefit as a proofreading activity. It might be that additional factors are required to regulate the p53 exonuclease and to couple its activity to that of the pol-prim to optimize the cooperation of the enzymes. One of these factors could be RPA whose titration in these kinds of assays shows a 1.5&#x02013;2-fold increased exchange reaction of mispaired nucleotides. Also, other factors or modifications are conceivable such as phosphorylation and acetylation (<xref ref-type="bibr" rid="gkf244c71">71</xref>,<xref ref-type="bibr" rid="gkf244c72">72</xref>). This view is in agreement with various <italic>in vivo</italic> experiments which show that wild-type p53 but not mutant p53 can increase fidelity of genomic DNA synthesis in living cells.</p></sec></body><back><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="gkf244f1"><label>Figure 1</label><caption><p> Complex formation of pol-prim and p53. (<bold>A</bold>) CEM cells crude extracts (60 &#x000b5;g, lane 1)were incubated with anti-SV40 T-Ag monoclonal antibody PAb101 (lane 3, crosslinked antibody resin with crude extract) and anti-p180 monoclonal antibody HP180-12 (lane 5, crosslinked antibodies with crude extract). The antibody HP180-12 precipitated both p180 and p53 from CEM crude extract (lane 5). The anti-SV40 T-Ag monoclonal antibody PAb101 did not precipitate p180 or p53 (lane 3). As a control for solubilized antibodies the crosslinked antibody&#x02013;protein G resins were incubating with loading buffer in parallel (lanes 2 and 4). The proteins were subjected to 10&#x00025; SDS gel electrophoresis and detected by immunoblotting with anti-p180 monoclonal antibody Hp180-7 and anti-p53 polyclonal antibody Ab-7. (<bold>B</bold>) Four subunits of pol-prim, p53 and all five polypeptides were expressed in High Five insect cells and purified as described in the Materials and Methods. The proteins (240 ng of immunoaffinity-purified pol-prim, 70 ng of p53 and 400 ng of p53&#x0002f;pol-prim complex; lanes 1, 2 and 3, respectively) were analyzed by SDS gel electrophoresis and subsequent staining with silver as described earlier (58).</p></caption><graphic xlink:href="gkf24401"/></fig><fig id="gkf244f2"><label>Figure 2</label><caption><p> Exonuclease activity of p53-associated and p53-free DNA pol-prim. (<bold>A</bold>) Increasing amounts of pol-prim with and without p53 were incubated with primer-template system. The reaction products were separated on a 20&#x00025; denaturating polyacrylamide gel and detected by autoradiography. The immunopurified p53&#x0002f;pol-prim (17.5 and 35 ng at 37&#x000b0;C; lanes 1 and 2, respectively) degraded radioactively labeled DNA, whereas the same amounts of the four subunit pol-prim did not (lanes 3 and 4). Labeled primers before incubation with proteins are shown in lane M. (<bold>B</bold>) To compare the degradation of primers with a paired and an unpaired 3&#x02032;-end, primer systems 1 and 2 were incubated with 10 ng of p53&#x0002f;pol-prim at 30&#x000b0;C for increasing times as indicated &#x0005b;lanes 1&#x02013;4, paired primer (lane M) and lanes 5&#x02013;8, primer with mismatched 3&#x02032;-end (lane&#x000a0;M&#x0002a;) incubated for 0.5, 2, 7 and 12 min, respectively&#x0005d;. After autoradiography the primers (lanes M and M&#x0002a;) and the exonuclease degradation products were quantified with the ImageQuant program. The value of the 3&#x02032;-unpaired primer (lane M&#x0002a;) was arbitrarily set to 100. The relative value of the paired primer (lane M) was 118 whereas the relative values of the exonuclease products were 7.1, 9.7, 14, 14.7, 10.9, 14.3, 16.4 and 18 (lanes 1&#x02013;8, respectively). As the intensity of the paired primer was greater than that of the 3&#x02032;-unpaired primer (lanes M and M&#x0002a;, respectively) the values of the exonuclease products of the paired primer (lanes 1&#x02013;4) were normalized to equal the radioactivity of both primers for the purpose of comparison. After 0.5, 2, 7 and 12&#x000a0;min the normalized values of the exonuclease products were 6.1, 8.2, 11.9 and 12.5 for the paired primer, and 10.9, 14.3, 16.4 and 18 for the unpaired primer, respectively.</p></caption><graphic xlink:href="gkf24402"/></fig><fig id="gkf244f3"><label>Figure 3</label><caption><p> Inhibition of p53 exonuclease activity by monoclonal antibodies. Increasing amounts of p53-specific monoclonal antibodies DO-1, PAb240 and PAb421 were titrated in an exonuclease assay containing equal amounts of p53&#x0002f;pol-prim to investigate a possible inhibitory effect of these antibodies. PAb240 (0.7 and 1.4 &#x000b5;g, lanes 5 and 6, respectively) and PAb421 (0.7 and 1.4 &#x000b5;g, lanes 8 and 9, respectively) inhibited the p53 exonuclease activity (lanes 4 and 7). DO-1 (0.7 and 1.4 &#x000b5;g, lanes 2 and 3, respectively) did not inhibit p53 exonuclease activity (lane 1). The products were analyzed by denaturating polyacrylamide gel electrophoresis and autoradiography.</p></caption><graphic xlink:href="gkf24403"/></fig><fig id="gkf244f4"><label>Figure 4</label><caption><p> DNA synthesis of p53-associated and p53-free DNA pol-prim on different primer-template systems. The ability of p53-associated (<bold>A</bold>) and p53-free pol-prim complexes (<bold>B</bold>) to extend either a paired or a mispaired 3&#x02032;-end primer-template system was compared. Increasing amounts of proteins were incubated with the primer-template system 1 (paired 3&#x02032;-end, lane M without pol-prim, and lanes 1&#x02013;4 in the presence of 0.09&#x02013;0.9 DNA polymerase units of each enzyme complex) and system 2 (mispaired 3&#x02032;-end, lane M&#x0002a; without pol-prim and lanes 5&#x02013;8 in the presence of 0.09&#x02013;0.9 DNA polymerase units of each enzyme complex) for 30 min at 37&#x000b0;C. The products were analyzed by denaturing polyacrylamide gel electrophoresis and autoradiography.</p></caption><graphic xlink:href="gkf24404"/></fig><fig id="gkf244f5"><label>Figure 5</label><caption><p> The elongation of a mispaired 3&#x02032;-end by p53&#x0002f;pol-prim complex is inhibited by PAb421. To determine whether the elongation of a mispaired 3&#x02032;-end primer depends on the exonuclease activity of p53 either untreated (0.7 and 1.4 &#x000b5;g, lanes 2 and 3, respectively) or heat-denatured (0.7 and 1.4 &#x000b5;g, lanes 5 and 6, respectively) purified PAb421 was added to the reaction mixture. Primer system 2 was incubated with 0.2 DNA polymerase units of p53&#x0002f;pol-prim for 30 min at 37&#x000b0;C in the presence (lanes 2, 3, 5 and 6) or absence (lanes 1 and 4) of antibody. The products were analyzed by denaturating polyacrylamide gel electrophoresis and autoradiography.</p></caption><graphic xlink:href="gkf24405"/></fig><fig id="gkf244f6"><label>Figure 6</label><caption><p> Exchange of a 3&#x02032;-unpaired nucleotide by p53-associated DNA pol-prim. Unlabeled primer-template systems containing either a paired (primer 1, <bold>A</bold>) or mispaired 3&#x02032;-end (primer 2, <bold>B</bold> and <bold>C</bold>) were incubated with 0.03 DNA polymerase units of p53&#x0002f;pol-prim in the presence of the radioactively labeled correct dNTP &#x0005b;dTTP to elongate primer 1 after the paired dCMP (A); dCTP to exchange the mispaired dGMP of primer 2 with the correct dCMP (B)&#x0005d; or incorrect dNTP &#x0005b;dATP to exchange the mispaired dGMP of primer 2 into the incorrect dAMP (C)&#x0005d;. For comparison, 16mer primers radioactively labeled at their 5&#x02032;-end were loaded in lanes M (primer 1) and M&#x0002a; (primer 2). The sequence of the template and the hybridized primers 1 and 2 are presented on the left.</p></caption><graphic xlink:href="gkf24406"/></fig></sec><ack><sec><title>ACKNOWLEDGEMENTS</title><p>We thank F. Grosse and R. W. P. Smith for the critical reading of the manuscript and discussions, M. Willitzer for the synthesis and purification of oligonucleotides and J. Fuchs for technical assistance. This study was supported by grants from the Deutsche Krebshilfe&#x0002f;Dr Mildred Scheel Stiftung 10-1127-Gr1; 10-1560-Gr2 and the Deutsche Forschungsgemeinschaft. The IMB is a Gottfried-Wilhelm-Leibniz-Institut and financially supported by the federal government and by the state of Th&#x000fc;ringen.</p></sec></ack><ref-list><title>REFERENCES</title><ref id="gkf244c1"><label>1.</label><citation citation-type="journal"><name><surname>Hansen</surname><given-names>R.</given-names></name> and Oren,M. (1997) p53: from inductive signal to cellular effect. <source>Curr. Opin. Genet. Dev.</source>, <volume>7</volume>, <fpage>46</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">9024633</pub-id></citation></ref><ref id="gkf244c2"><label>2.</label><citation citation-type="journal"><name><surname>Janus</surname><given-names>F.</given-names></name>, Albrechtsen,N., Dornreiter,I., Wiesm&#x000fc;ller,L., Grosse,F. and Deppert,W. (1999) The dual role model for p53 in maintaining genomic integrity. <source>Cell. Mol. Life Sci.</source>, <volume>55</volume>, <fpage>12</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">10065148</pub-id></citation></ref><ref id="gkf244c3"><label>3.</label><citation citation-type="journal"><name><surname>Levine</surname><given-names>A.J.</given-names></name> (1997) p53, the cellular gatekeeper for growth and division. <source>Cell</source>, <volume>88</volume>, <fpage>323</fpage>&#x02013;<lpage>331</lpage>.<pub-id pub-id-type="pmid">9039259</pub-id></citation></ref><ref id="gkf244c4"><label>4.</label><citation citation-type="journal"><name><surname>Meek</surname><given-names>D.W.</given-names></name> (1999) Mechanisms of switching on p53: a role for covalent modification? <source>Oncogene</source>, <volume>18</volume>, <fpage>7666</fpage>&#x02013;<lpage>7675</lpage>.<pub-id pub-id-type="pmid">10618706</pub-id></citation></ref><ref id="gkf244c5"><label>5.</label><citation citation-type="journal"><name><surname>Oren</surname><given-names>M.</given-names></name> (1999) Regulation of the p53 tumor suppressor protein. <source>J. Biol. Chem.</source>, <volume>274</volume>, <fpage>36031</fpage>&#x02013;<lpage>36034</lpage>.<pub-id pub-id-type="pmid">10593882</pub-id></citation></ref><ref id="gkf244c6"><label>6.</label><citation citation-type="journal"><name><surname>Prives</surname><given-names>C.</given-names></name> and Hall,P.A. (1999) The p53 pathway. <source>J. Pathol.</source>, <volume>187</volume>, <fpage>112</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">10341712</pub-id></citation></ref><ref id="gkf244c7"><label>7.</label><citation citation-type="journal"><name><surname>Steele</surname><given-names>R.J.</given-names></name>, Thompson,A.M., Hall,P.A. and Lane,D.P. (1998) The p53 tumour suppressor gene. <source>Br. J. Surg.</source>, <volume>85</volume>, <fpage>1460</fpage>&#x02013;<lpage>1407</lpage>.<pub-id pub-id-type="pmid">9823903</pub-id></citation></ref><ref id="gkf244c8"><label>8.</label><citation citation-type="journal"><name><surname>Harris</surname><given-names>C.C.</given-names></name> and Hollstein,M. (1993) Clinical implications of the tumor-suppressor gene. <source>N. Engl. J. Med.</source>, <volume>329</volume>, <fpage>1318</fpage>&#x02013;<lpage>1327</lpage>.<pub-id pub-id-type="pmid">8413413</pub-id></citation></ref><ref id="gkf244c9"><label>9.</label><citation citation-type="journal"><name><surname>Hollstein</surname><given-names>M.</given-names></name>, Sidransky,D., Vogelstein,B. and Harris,C.C. (1991) p53 mutations in human cancers. <source>Science</source>, <volume>253</volume>, <fpage>49</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">1905840</pub-id></citation></ref><ref id="gkf244c10"><label>10.</label><citation citation-type="journal"><name><surname>Vogelstein</surname><given-names>B.</given-names></name> and Kinzler,K.W. (1992) p53 function and dysfunction. <source>Cell</source>, <volume>70</volume>, <fpage>523</fpage>&#x02013;<lpage>526</lpage>.<pub-id pub-id-type="pmid">1505019</pub-id></citation></ref><ref id="gkf244c11"><label>11.</label><citation citation-type="journal"><name><surname>Ikawa</surname><given-names>S.</given-names></name>, Nakagawara,A. and Ikawa,Y. (1999) p53 family genes: structural comparison, expression and mutation. <source>Cell Death Differ.</source>, <volume>6</volume>, <fpage>1154</fpage>&#x02013;<lpage>1161</lpage>.<pub-id pub-id-type="pmid">10637430</pub-id></citation></ref><ref id="gkf244c12"><label>12.</label><citation citation-type="journal"><name><surname>Levrero</surname><given-names>M.</given-names></name>, Laurenzi,V.D., Costanzo,A., Gong,J., Melino,G. and Wang,J.Y. (1999) Structure, function and regulation of p63 and p73. <source>Cell Death Differ.</source>, <volume>6</volume>, <fpage>1146</fpage>&#x02013;<lpage>1153</lpage>.<pub-id pub-id-type="pmid">10637429</pub-id></citation></ref><ref id="gkf244c13"><label>13.</label><citation citation-type="journal"><name><surname>Donehower</surname><given-names>L.A.</given-names></name>, Harvey,M., Slagle,B.L., McArthur,M.J., Montgomery,C.A., Butel,J.A. and Bradley,A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. <source>Nature</source>, <volume>356</volume>, <fpage>215</fpage>&#x02013;<lpage>221</lpage>.<pub-id pub-id-type="pmid">1552940</pub-id></citation></ref><ref id="gkf244c14"><label>14.</label><citation citation-type="journal"><name><surname>Agarwal</surname><given-names>M.L.</given-names></name>, Taylor,W.R., Chernov,M.V., Chernova,O.B. and Stark,G.R. (1998) The p53 network. <source>J. Biol. Chem.</source>, <volume>273</volume>, <fpage>1</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">9417035</pub-id></citation></ref><ref id="gkf244c15"><label>15.</label><citation citation-type="journal"><name><surname>el-Deiry</surname><given-names>W.S.</given-names></name>, Tokino,T., Velculescu,V.E., Levy,D.B., Parsons,R., Trent,J.M., Lin,D., Mercer,W.E., Kinzler,K.W. and Vogelstein,B. (1993) WAF1, a potential mediator of p53 tumor suppression. <source>Cell</source>, <volume>75</volume>, <fpage>817</fpage>&#x02013;<lpage>825</lpage>.<pub-id pub-id-type="pmid">8242752</pub-id></citation></ref><ref id="gkf244c16"><label>16.</label><citation citation-type="journal"><name><surname>Hermeking</surname><given-names>H.</given-names></name>, Lengauer,C., Polyak,K., He,T.C., Zhang,L., Thiagalingam,S., Kinzler,K.W. and Vogelstein,B. (1997) 14-3-3 sigma is a p53-regulated inhibitor of G2&#x0002f;M progression. <source>Mol. Cell</source>, <volume>1</volume>, <fpage>3</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">9659898</pub-id></citation></ref><ref id="gkf244c17"><label>17.</label><citation citation-type="journal"><name><surname>Marx</surname><given-names>J.</given-names></name> (1993) How p53 suppresses cell growth. <source>Science</source>, <volume>262</volume>, <fpage>1644</fpage>&#x02013;<lpage>1645</lpage>.<pub-id pub-id-type="pmid">8259506</pub-id></citation></ref><ref id="gkf244c18"><label>18.</label><citation citation-type="journal"><name><surname>Miyashita</surname><given-names>T.</given-names></name> and Reed,J.C. (1995) Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. <source>Cell</source>, <volume>80</volume>, <fpage>293</fpage>&#x02013;<lpage>299</lpage>.<pub-id pub-id-type="pmid">7834749</pub-id></citation></ref><ref id="gkf244c19"><label>19.</label><citation citation-type="journal"><name><surname>Offer</surname><given-names>H.</given-names></name>, Wolkowicz,R., Matas,D., Blumenstein,S., Livneh,Z. and Rotter,V. (1999) Direct involvement of p53 in the base excision repair pathway of the DNA repair machinery. <source>FEBS Lett.</source>, <volume>450</volume>, <fpage>197</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">10359074</pub-id></citation></ref><ref id="gkf244c20"><label>20.</label><citation citation-type="journal"><name><surname>Therrien</surname><given-names>J.P.</given-names></name>, Drouin,R., Baril,C. and Drobetsky,E.A. (1999) Human cells compromised for p53 function exhibit defective global and transcription-coupled nucleotide excision repair, whereas cells compromised for pRb function are defective only in global repair. <source>Proc. Natl Acad. Sci. USA</source>, <volume>96</volume>, <fpage>15038</fpage>&#x02013;<lpage>15043</lpage>.<pub-id pub-id-type="pmid">10611334</pub-id></citation></ref><ref id="gkf244c21"><label>21.</label><citation citation-type="journal"><name><surname>Wang</surname><given-names>X.W.</given-names></name>, Vermeulen,W., Coursen,J.D., Gibson,M., Lupold,S.E., Forrester,K., Xu,G., Elmore,L., Yeh,H., Hoeijmakers,J.H. and Harris,C.C. (1996) The XPB and XPD DNA helicases are components of the p53-mediated apoptosis pathway. <source>Genes Dev.</source>, <volume>10</volume>, <fpage>1219</fpage>&#x02013;<lpage>1232</lpage>.<pub-id pub-id-type="pmid">8675009</pub-id></citation></ref><ref id="gkf244c22"><label>22.</label><citation citation-type="journal"><name><surname>Wang</surname><given-names>X.W.</given-names></name>, Yeh,H., Schaeffer,L., Roy,R., Moncollin,V., Egly,J.M., Mang,Z., Freidberg,E.C., Evans,M.K., Taffe,B.G. <italic>et al.</italic> (1995) p53 modulation of TFIIH-associated nucleotide excision repair activity. <source>Nature Genet.</source>, <volume>10</volume>, <fpage>188</fpage>&#x02013;<lpage>195</lpage>.<pub-id pub-id-type="pmid">7663514</pub-id></citation></ref><ref id="gkf244c23"><label>23.</label><citation citation-type="journal"><name><surname>Wilcock</surname><given-names>D.</given-names></name> and Lane,D.P. (1991) Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. <source>Nature</source>, <volume>349</volume>, <fpage>429</fpage>&#x02013;<lpage>431</lpage>.<pub-id pub-id-type="pmid">1671528</pub-id></citation></ref><ref id="gkf244c24"><label>24.</label><citation citation-type="journal"><name><surname>Lee</surname><given-names>S.</given-names></name>, Cavallo,L. and Griffith,J. (1997) Human p53 binds Holliday junctions strongly and facilitates their cleavage. <source>J. Biol. Chem.</source>, <volume>272</volume>, <fpage>7532</fpage>&#x02013;<lpage>7539</lpage>.<pub-id pub-id-type="pmid">9054458</pub-id></citation></ref><ref id="gkf244c25"><label>25.</label><citation citation-type="journal"><name><surname>Mekeel</surname><given-names>K.L.</given-names></name>, Tang,W., Kachnic,L.A., Luo,C.M., DeFrank,J.S. and Powell,S.N. (1997) Inactivation of p53 results in high rates of homologous recombination. <source>Oncogene</source>, <volume>14</volume>, <fpage>1847</fpage>&#x02013;<lpage>1857</lpage>.<pub-id pub-id-type="pmid">9150391</pub-id></citation></ref><ref id="gkf244c26"><label>26.</label><citation citation-type="journal"><name><surname>St&#x000fc;rzbecher</surname><given-names>H.W.</given-names></name>, Donzelmann,B., Henning,W., Knippschild,U. and Buchhop,S. (1996) p53 is linked directly to homologous recombination processes via RAD51&#x0002f;RecA protein interaction. <source>EMBO J.</source>, <volume>15</volume>, <fpage>1992</fpage>&#x02013;<lpage>2002</lpage>.<pub-id pub-id-type="pmid">8617246</pub-id></citation></ref><ref id="gkf244c27"><label>27.</label><citation citation-type="journal"><name><surname>Wiesm&#x000fc;ller</surname><given-names>L.</given-names></name>, Cammenga,J. and Deppert,W. (1996) <italic>In vivo</italic> assay of p53 function in homologous recombination between simian virus 40 chromosomes. <source>J. Virol.</source>, <volume>70</volume>, <fpage>737</fpage>&#x02013;<lpage>744</lpage>.<pub-id pub-id-type="pmid">8551610</pub-id></citation></ref><ref id="gkf244c28"><label>28.</label><citation citation-type="journal"><name><surname>Dutta</surname><given-names>A.</given-names></name>, Ruppert,J.M., Aster,J.C. and Winchester,E. (1993) Inhibition of DNA replication factor RPA by p53. <source>Nature</source>, <volume>365</volume>, <fpage>79</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">8361542</pub-id></citation></ref><ref id="gkf244c29"><label>29.</label><citation citation-type="journal"><name><surname>K&#x000fc;hn</surname><given-names>C.</given-names></name>, M&#x000fc;ller,F., Melle,C., Nasheuer,H.-P., Janus,F., Deppert,W. and Grosse,F. (1999) Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase &#x003b1;. <source>Oncogene</source>, <volume>18</volume>, <fpage>769</fpage>&#x02013;<lpage>774</lpage>.<pub-id pub-id-type="pmid">9989827</pub-id></citation></ref><ref id="gkf244c30"><label>30.</label><citation citation-type="journal"><name><surname>Huang</surname><given-names>P.</given-names></name> (1998) Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 protein. <source>Oncogene</source>, <volume>17</volume>, <fpage>261</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">9690508</pub-id></citation></ref><ref id="gkf244c31"><label>31.</label><citation citation-type="journal"><name><surname>Mummenbrauer</surname><given-names>T.</given-names></name>, Janus,F., M&#x000fc;ller,B., Wiesm&#x000fc;ller,L., Deppert,W. and Grosse,F. (1996) p53 protein exhibits 3&#x02032;-to-5&#x02032; exonuclease activity. <source>Cell</source>, <volume>85</volume>, <fpage>1089</fpage>&#x02013;<lpage>1099</lpage>.<pub-id pub-id-type="pmid">8674115</pub-id></citation></ref><ref id="gkf244c32"><label>32.</label><citation citation-type="journal"><name><surname>Skalski</surname><given-names>V.</given-names></name>, Lin,Z.Y., Choi,B.Y. and Brown,K.R. (2000) Substrate specificity of the p53-associated 3&#x02032;&#x02013;5&#x02032; exonuclease. <source>Oncogene</source>, <volume>19</volume>, <fpage>3321</fpage>&#x02013;<lpage>3329</lpage>.<pub-id pub-id-type="pmid">10918588</pub-id></citation></ref><ref id="gkf244c33"><label>33.</label><citation citation-type="journal"><name><surname>Bakhanashvili</surname><given-names>M.</given-names></name> (2001) Exonucleolytic proofreading by p53 protein. <source>Eur. J. Biochem.</source>, <volume>268</volume>, <fpage>2047</fpage>&#x02013;<lpage>2054</lpage>.<pub-id pub-id-type="pmid">11277927</pub-id></citation></ref><ref id="gkf244c34"><label>34.</label><citation citation-type="journal"><name><surname>Bakhanashvili</surname><given-names>M.</given-names></name> (2001) p53 enhances the fidelity of DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase. <source>Oncogene</source>, <volume>20</volume>, <fpage>7635</fpage>&#x02013;<lpage>7644</lpage>.<pub-id pub-id-type="pmid">11753641</pub-id></citation></ref><ref id="gkf244c35"><label>35.</label><citation citation-type="journal"><name><surname>H&#x000fc;bscher</surname><given-names>U.</given-names></name>, Nasheuer,H.P. and Syv&#x000e4;oja,J. (2000) Eukaryotic DNA polymerases, a growing family. <source>Trends Biochem. Sci.</source>, <volume>25</volume>, <fpage>143</fpage>&#x02013;<lpage>147</lpage>.<pub-id pub-id-type="pmid">10694886</pub-id></citation></ref><ref id="gkf244c36"><label>36.</label><citation citation-type="journal"><name><surname>Achanta</surname><given-names>G.</given-names></name>, Pelicano,H., Feng,L., Plunkett,W. and Huang,P. (2001) Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage. <source>Cancer Res.</source>, <volume>61</volume>, <fpage>8723</fpage>&#x02013;<lpage>8729</lpage>.<pub-id pub-id-type="pmid">11751391</pub-id></citation></ref><ref id="gkf244c37"><label>37.</label><citation citation-type="journal"><name><surname>Feng</surname><given-names>L.</given-names></name>, Achanta,G., Pelicano,H., Zhang,W., Plunkett,W. and Huang,P. (2000) Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage. <source>Int. J. Mol. Med.</source>, <volume>5</volume>, <fpage>597</fpage>&#x02013;<lpage>604</lpage>.<pub-id pub-id-type="pmid">10812007</pub-id></citation></ref><ref id="gkf244c38"><label>38.</label><citation citation-type="journal"><name><surname>Zhou</surname><given-names>Y.</given-names></name>, Achanta,G., Pelicano,H., Gandhi,V., Plunkett,W. and Huang,P. (2002) Action of (E)-2&#x02032;-deoxy-2&#x02032;-(fluoromethylene)cytidine on DNA metabolism: incorporation, excision and cellular response. <source>Mol. Pharmacol.</source>, <volume>61</volume>, <fpage>222</fpage>&#x02013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">11752224</pub-id></citation></ref><ref id="gkf244c39"><label>39.</label><citation citation-type="journal"><name><surname>Bialek</surname><given-names>G.</given-names></name>, Nasheuer,H.-P., Goetz,H. and Grosse,F. (1989) Exonucleolytic proofreading increases the accuracy of DNA synthesis by human lymphoblast DNA polymerase &#x003b1;-DNA primase. <source>EMBO J.</source>, <volume>8</volume>, <fpage>1833</fpage>&#x02013;<lpage>1839</lpage>.<pub-id pub-id-type="pmid">2527747</pub-id></citation></ref><ref id="gkf244c40"><label>40.</label><citation citation-type="journal"><name><surname>Chen</surname><given-names>Y.-C.</given-names></name>, Bohn,E.W., Planck,S.R. and Wilson,S.R. (1979) Mouse DNA polymerase &#x003b1;: subunit structure and identification of a species with associated exonuclease. <source>J. Biol. Chem.</source>, <volume>254</volume>, <fpage>11678</fpage>&#x02013;<lpage>11687</lpage>.<pub-id pub-id-type="pmid">500666</pub-id></citation></ref><ref id="gkf244c41"><label>41.</label><citation citation-type="journal"><name><surname>Ottiger</surname><given-names>H.P.</given-names></name> and H&#x000fc;bscher,U. (1984) Mammalian DNA polymerase &#x003b1; holoenzyme with possible functions at the leading and lagging strand of the replication fork. <source>Proc. Natl Acad. Sci. USA</source>, <volume>81</volume>, <fpage>3993</fpage>&#x02013;<lpage>3997</lpage>.<pub-id pub-id-type="pmid">6588375</pub-id></citation></ref><ref id="gkf244c42"><label>42.</label><citation citation-type="journal"><name><surname>Zhou</surname><given-names>J.</given-names></name>, Ahn,H., Wilson,S.H. and Prives,C. (2001) A role for p53 in base excision repair. <source>EMBO J.</source>, <volume>20</volume>, <fpage>914</fpage>&#x02013;<lpage>923</lpage>.<pub-id pub-id-type="pmid">11179235</pub-id></citation></ref><ref id="gkf244c43"><label>43.</label><citation citation-type="journal"><name><surname>Loeb</surname><given-names>L.A.</given-names></name> and Kunkel,T.A. (1982) Fidelity of DNA synthesis. <source>Annu. Rev. Biochem.</source>, <volume>52</volume>, <fpage>429</fpage>&#x02013;<lpage>457</lpage>.</citation></ref><ref id="gkf244c44"><label>44.</label><citation citation-type="journal"><name><surname>Cahill</surname><given-names>D.P.</given-names></name>, Kinzler,K.W., Vogelstein,B. and Lengauer,C. (1999) Genetic instability and darwinian selection in tumours. <source>Trends Cell Biol.</source>, <volume>9</volume>, <fpage>M57</fpage>&#x02013;<lpage>M60</lpage>.<pub-id pub-id-type="pmid">10611684</pub-id></citation></ref><ref id="gkf244c45"><label>45.</label><citation citation-type="journal"><name><surname>Loeb</surname><given-names>L.A.</given-names></name> (1998) Cancer cells exhibit a mutator phenotype. <source>Adv. Cancer Res.</source>, <volume>72</volume>, <fpage>25</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="pmid">9338073</pub-id></citation></ref><ref id="gkf244c46"><label>46.</label><citation citation-type="journal"><name><surname>Stoler</surname><given-names>D.L.</given-names></name>, Chen,N., Basik,M., Kahlenberg,M.S., Rodriguez-Bigas,M.S., Petrelli,N.J. and Anderson,G.R. (1999) The onset and extent of genomic instability in sporadic colorectal tumor progression. <source>Proc. Natl Acad. Sci. USA</source>, <volume>96</volume>, <fpage>15121</fpage>&#x02013;<lpage>15126</lpage>.<pub-id pub-id-type="pmid">10611348</pub-id></citation></ref><ref id="gkf244c47"><label>47.</label><citation citation-type="journal"><name><surname>Kautz</surname><given-names>A.</given-names></name>, Schneider,A., Weisshart,K., Geiger,C. and Nasheuer,H.P. (2001) Different regions of primase subunit p48 control mouse polyomavirus and simian virus 40 DNA replication <italic>in vitro</italic>. <source>J. Virol.</source>, <volume>75</volume>, <fpage>1751</fpage>&#x02013;<lpage>1760</lpage>.<pub-id pub-id-type="pmid">11160673</pub-id></citation></ref><ref id="gkf244c48"><label>48.</label><citation citation-type="journal"><name><surname>Kautz</surname><given-names>A.</given-names></name>, Weisshart,K., Schneider,A., Grosse,F. and Nasheuer,H.P. (2001) Amino acids 257 to 288 of mouse p48 control the cooperation of polyomavirus large T antigen, replication protein A and DNA polymerase &#x003b1;-primase to synthesize DNA <italic>in vitro</italic>. <source>J. Virol.</source>, <volume>75</volume>, <fpage>8569</fpage>&#x02013;<lpage>8578</lpage>.<pub-id pub-id-type="pmid">11507202</pub-id></citation></ref><ref id="gkf244c49"><label>49.</label><citation citation-type="journal"><name><surname>Stadlbauer</surname><given-names>F.</given-names></name>, Brueckner,A., Rehfuess,C., Eckerskorn,C., Lottspeich,F., F&#x000f6;rster,V., Tseng,B.Y. and Nasheuer,H.-P. (1994) DNA replication <italic>in&#x000a0;vitro</italic> by recombinant DNA-polymerase-alpha-primase. <source>Eur. J. Biochem.</source>, <volume>222</volume>, <fpage>781</fpage>&#x02013;<lpage>793</lpage>.<pub-id pub-id-type="pmid">8026492</pub-id></citation></ref><ref id="gkf244c50"><label>50.</label><citation citation-type="journal"><name><surname>Stadlbauer</surname><given-names>F.</given-names></name>, Voitenleitner,C., Br&#x000fc;ckner,A., Fanning,E. and Nasheuer,H.-P. (1996) Species-specific replication of simian virus 40 DNA <italic>in vitro</italic> requires the p180 subunit of human DNA polymerase alpha-primase. <source>Mol. Cell. Biol.</source>, <volume>16</volume>, <fpage>94</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">8524333</pub-id></citation></ref><ref id="gkf244c51"><label>51.</label><citation citation-type="journal"><name><surname>Bargonetti</surname><given-names>J.</given-names></name>, Friedman,P.N., Kern,S.E., Vogelstein,B. and Prives,C. (1991) Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. <source>Cell</source>, <volume>65</volume>, <fpage>1083</fpage>&#x02013;<lpage>1091</lpage>.<pub-id pub-id-type="pmid">1646078</pub-id></citation></ref><ref id="gkf244c52"><label>52.</label><citation citation-type="journal"><name><surname>Nesper</surname><given-names>J.</given-names></name>, Smith,R.W.P., Kautz,A.R., Sock,E., Wegner,M., Grummt,F. and Nasheuer,H.-P. (1997) A cell-free replication system for human polyomavirus JC DNA. <source>J. Virol.</source>, <volume>71</volume>, <fpage>7421</fpage>&#x02013;<lpage>7428</lpage>.<pub-id pub-id-type="pmid">9311820</pub-id></citation></ref><ref id="gkf244c53"><label>53.</label><citation citation-type="journal"><name><surname>Schub</surname><given-names>O.</given-names></name>, Rohaly,G., Smith,R.W., Schneider,A., Dehde,S., Dornreiter,I. and Nasheuer,H.P. (2001) Multiple phosphorylation sites of DNA polymerase &#x003b1;-primase cooperate to regulate the initiation of DNA replication <italic>in vitro</italic>. <source>J. Biol. Chem.</source>, <volume>276</volume>, <fpage>38076</fpage>&#x02013;<lpage>38083</lpage>.<pub-id pub-id-type="pmid">11502743</pub-id></citation></ref><ref id="gkf244c54"><label>54.</label><citation citation-type="journal"><name><surname>Dehde</surname><given-names>S.</given-names></name>, Rohaldy,G., Schub,O., Nasheuer,H.P., Bohn,W., Chemnitz,J., Deppert,W. and Dornreiter,I. (2001) Two immunologically distinct human DNA polymerase &#x003b1;-primase subpopulations are involved in cellular DNA replication. <source>Mol. Cell. Biol.</source>, <volume>21</volume>, <fpage>2581</fpage>&#x02013;<lpage>2593</lpage>.<pub-id pub-id-type="pmid">11259605</pub-id></citation></ref><ref id="gkf244c55"><label>55.</label><citation citation-type="journal"><name><surname>Harlow</surname><given-names>E.</given-names></name>, Crawford,L.V., Pim,D.C. and Williamson,N.M. (1981) Monoclonal antibodies specific for simian virus 40 tumor antigens. <source>J. Virol.</source>, <volume>39</volume>, <fpage>861</fpage>&#x02013;<lpage>869</lpage>.<pub-id pub-id-type="pmid">6169844</pub-id></citation></ref><ref id="gkf244c56"><label>56.</label><citation citation-type="other"><name><surname>Harlow</surname><given-names>E.</given-names></name> and Lane,D. (1988) <italic>Antibodies: A Laboratory Manual</italic>. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.</citation></ref><ref id="gkf244c57"><label>57.</label><citation citation-type="journal"><name><surname>Nasheuer</surname><given-names>H.-P.</given-names></name> and Grosse,F. (1987) Immunoaffinity-purified DNA polymerase &#x003b1; displays novel properties. <source>Biochemistry</source>, <volume>26</volume>, <fpage>8458</fpage>&#x02013;<lpage>8466</lpage>.<pub-id pub-id-type="pmid">3442669</pub-id></citation></ref><ref id="gkf244c58"><label>58.</label><citation citation-type="journal"><name><surname>Nasheuer</surname><given-names>H.-P.</given-names></name> and Grosse,F. (1988) DNA polymerase &#x003b1;-primase from calf thymus: Determination of the polypeptide responsible for primase activity. <source>J. Biol. Chem.</source>, <volume>263</volume>, <fpage>8981</fpage>&#x02013;<lpage>8988</lpage>.<pub-id pub-id-type="pmid">3379056</pub-id></citation></ref><ref id="gkf244c59"><label>59.</label><citation citation-type="journal"><name><surname>Bialek</surname><given-names>G.</given-names></name> and Grosse,F. (1993) An error-correcting proofreading exonuclease-polymerase that copurifies with DNA-polymerase-&#x003b1;-primase. <source>J. Biol. Chem.</source>, <volume>268</volume>, <fpage>6024</fpage>&#x02013;<lpage>6033</lpage>.<pub-id pub-id-type="pmid">8383685</pub-id></citation></ref><ref id="gkf244c60"><label>60.</label><citation citation-type="other"><name><surname>Sambrook</surname><given-names>J.</given-names></name>, Fritsch,E.F. and Maniatis,T. (1989) <italic>Molecular Cloning: A Laboratory Manual</italic>. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.</citation></ref><ref id="gkf244c61"><label>61.</label><citation citation-type="journal"><name><surname>Bradford</surname><given-names>M.M.</given-names></name> (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. <source>Anal. Biochem.</source>, <volume>72</volume>, <fpage>248</fpage>&#x02013;<lpage>254</lpage>.<pub-id pub-id-type="pmid">942051</pub-id></citation></ref><ref id="gkf244c62"><label>62.</label><citation citation-type="journal"><name><surname>Roberts</surname><given-names>J.D.</given-names></name>, Thomas,D.C. and Kunkel,T.A. (1991) Exonucleolytic proofreading of leading and lagging strand DNA replication errors. <source>Proc. Natl Acad. Sci. USA</source>, <volume>88</volume>, <fpage>3465</fpage>&#x02013;<lpage>3469</lpage>.<pub-id pub-id-type="pmid">1901658</pub-id></citation></ref><ref id="gkf244c63"><label>63.</label><citation citation-type="journal"><name><surname>Bae</surname><given-names>S.H.</given-names></name>, Bae,K.H., Kim,J.A. and Seo,Y.S. (2001) RPA governs endonuclease switching during processing of Okazaki fragments in eukaryotes. <source>Nature</source>, <volume>412</volume>, <fpage>456</fpage>&#x02013;<lpage>461</lpage>.<pub-id pub-id-type="pmid">11473323</pub-id></citation></ref><ref id="gkf244c64"><label>64.</label><citation citation-type="journal"><name><surname>Budd</surname><given-names>M.E.</given-names></name> and Campbell,J.L. (1997) A yeast replicative helicase, Dna2 helicase, interacts with yeast FEN-1 nuclease in carrying out its essential function. <source>Mol. Cell. Biol.</source>, <volume>17</volume>, <fpage>2136</fpage>&#x02013;<lpage>2142</lpage>.<pub-id pub-id-type="pmid">9121462</pub-id></citation></ref><ref id="gkf244c65"><label>65.</label><citation citation-type="journal"><name><surname>Vallen</surname><given-names>E.A.</given-names></name> and Cross,F.R. (1995) Mutations in RAD27 define a potential link between G1 cyclins and DNA replication. <source>Mol. Cell. Biol.</source>, <volume>15</volume>, <fpage>4291</fpage>&#x02013;<lpage>4302</lpage>.<pub-id pub-id-type="pmid">7623823</pub-id></citation></ref><ref id="gkf244c66"><label>66.</label><citation citation-type="journal"><name><surname>Nishino</surname><given-names>H.</given-names></name>, Kn&#x000f6;ll,A., Buettner,V.L., Frisk,C.S., Maruta,Y., Haavid,J.F. and Sommer,S.S. (1995) p53 wild-type and p53 nullizygous Big Blue transgenic mice have similar frequencies and patterns of observed mutation in liver, spleen and brain. <source>Oncogene</source>, <volume>11</volume>, <fpage>263</fpage>&#x02013;<lpage>270</lpage>.<pub-id pub-id-type="pmid">7624143</pub-id></citation></ref><ref id="gkf244c67"><label>67.</label><citation citation-type="journal"><name><surname>Sands</surname><given-names>A.T.</given-names></name>, Suraokar,M.B., Sanchez,A., Marth,J.E., Donehower,L.A. and Bradley,A. (1995) p53 deficiency does not affect the accumulation of point mutations in a transgene target. <source>Proc. Natl Acad. Sci. USA</source>, <volume>92</volume>, <fpage>8517</fpage>&#x02013;<lpage>8521</lpage>.<pub-id pub-id-type="pmid">7667322</pub-id></citation></ref><ref id="gkf244c68"><label>68.</label><citation citation-type="journal"><name><surname>Buettner</surname><given-names>V.L.</given-names></name>, Hill,K.A., Nishino,H., Schaid,D.J., Frisk,C.S. and Sommer,S.S. (1996) Increased mutation frequency and altered spectrum in one of four thymic lymphomas derived from tumor prone p53&#x0002f;Big Blue double transgenic mice. <source>Oncogene</source>, <volume>13</volume>, <fpage>2407</fpage>&#x02013;<lpage>2413</lpage>.<pub-id pub-id-type="pmid">8957082</pub-id></citation></ref><ref id="gkf244c69"><label>69.</label><citation citation-type="journal"><name><surname>Havre</surname><given-names>P.A.</given-names></name>, Yuan,J., Hedrick,L., Cho,K.R. and Glazer,P.R. (1995) p53 inactivation by HPV16 E6 results in increased mutagenesis in human cells. <source>Cancer Res.</source>, <volume>44</volume>, <fpage>4420</fpage>&#x02013;<lpage>4424</lpage>.</citation></ref><ref id="gkf244c70"><label>70.</label><citation citation-type="other"><name><surname>Melle</surname><given-names>C.</given-names></name> (2000) Komplexbildung zwischen der DNA Polymerase &#x003b1;-Primase und dem Tumorsuppressorprotein p53. PhD Dissertation, Friedrich-Schiller-Universit&#x000e4;t, Jena, Germany.</citation></ref><ref id="gkf244c71"><label>71.</label><citation citation-type="journal"><name><surname>Ko</surname><given-names>L.J.</given-names></name> and Prives,C. (1996) p53: puzzle and paradigm. <source>Genes Dev.</source>, <volume>10</volume>, <fpage>1054</fpage>&#x02013;<lpage>1072</lpage>.<pub-id pub-id-type="pmid">8654922</pub-id></citation></ref><ref id="gkf244c72"><label>72.</label><citation citation-type="journal"><name><surname>Prives</surname><given-names>C.</given-names></name> and Manley,J.L. (2001) Why is p53 acetylated? <source>Cell</source>, <volume>107</volume>, <fpage>815</fpage>&#x02013;<lpage>818</lpage>.<pub-id pub-id-type="pmid">11779456</pub-id></citation></ref></ref-list></back></article> 